What antibiotics are used to treat infectious colitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotics for Infectious Colitis

For infectious colitis, metronidazole is the first-line antibiotic for Clostridioides difficile infection (CDI), while specific antibiotic choices for other causes should be guided by the identified pathogen. 1, 2

Clostridioides difficile Infection (CDI)

First-line Treatment

  • Non-severe CDI:

    • Metronidazole 500 mg orally three times daily for 10 days 1
    • Consider stopping the inciting antibiotic if possible 1, 2
  • Severe CDI (WBC >15,000 cells/mL OR serum creatinine >1.5 mg/dL):

    • Vancomycin 125 mg orally four times daily for 10 days 1, 2, 3
  • Fulminant CDI (hypotension, shock, ileus, megacolon):

    • Vancomycin 500 mg orally four times daily PLUS
    • Metronidazole 500 mg IV every 8 hours 2
    • If oral therapy impossible: Metronidazole 500 mg IV three times daily PLUS intracolonic vancomycin 500 mg in 100 mL saline every 4-12 hours 1

Recurrent CDI

  • First recurrence: Same as initial episode based on severity 1
  • Second or later recurrences: Vancomycin in tapered/pulsed regimen 1, 2:
    • 125 mg four times daily for 10-14 days
    • 125 mg twice daily for 7 days
    • 125 mg once daily for 7 days
    • 125 mg every 2-3 days for 2-8 weeks

Other Infectious Causes of Colitis

Bacterial Pathogens

  • Salmonella, Shigella, Campylobacter, E. coli:

    • Ciprofloxacin 500 mg twice daily for 5-7 days (if susceptible) 4
    • Alternative: Azithromycin 500 mg daily for 3 days
  • Staphylococcal enterocolitis:

    • Vancomycin 125-250 mg orally four times daily for 7-10 days 3
    • Total daily dosage: 500 mg to 2 g administered orally in 3-4 divided doses

Special Populations

  • Pediatric patients:

    • For CDI: 40 mg/kg/day of vancomycin in 3-4 divided doses (max 2g/day) 2, 3
    • For metronidazole: 30 mg/kg/day divided into three doses (max 500 mg/dose)
  • Patients with β-lactam allergy:

    • For gram-positive infections: Consider macrolides, cotrimoxazole, or glycopeptides based on the specific pathogen 1

Diagnostic Approach

  1. Obtain stool samples for:

    • C. difficile toxin assay (if antibiotic exposure or healthcare setting)
    • Bacterial culture and sensitivity
    • Multiplex PCR for common enteric pathogens 4
  2. Consider sigmoidoscopy or colonoscopy for:

    • Patients with severe symptoms
    • When pseudomembranous colitis is suspected
    • Cases not responding to empiric therapy 2

Treatment Pearls and Pitfalls

Pearls

  • Discontinue the inciting antibiotic whenever possible 1, 2
  • Avoid antiperistaltic agents and opiates in infectious colitis 1
  • Handwashing with soap and water (not alcohol-based sanitizers) is essential for preventing C. difficile spread 2

Pitfalls

  • Antibiotics with highest risk for causing CDI include clindamycin, fluoroquinolones, and cephalosporins 2
  • Even vancomycin and metronidazole can cause CDI when used parenterally 5
  • Oral vancomycin is poorly absorbed and should not be used for systemic infections 3
  • Metronidazole has decreased efficacy against C. difficile compared to vancomycin and has higher risk of neurotoxicity 2

Monitoring and Follow-up

  • Monitor stool frequency, consistency, and systemic symptoms
  • Treatment response: Decreased stool frequency and improved consistency after 3 days 1
  • Consider surgical consultation for toxic megacolon, perforation, or severe disease not responding to antibiotics 1, 2

Remember that the choice of antibiotic should be guided by the identified pathogen, local resistance patterns, and patient factors such as severity of illness and comorbidities.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Clostridioides difficile Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.